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INTRODUCTION
Transcatheter stent valves (both purpose-built and off-label) are implanted to relieve mitral valve failure -whether native, bioprosthetic, or after annuloplasty -when the risk of mitral valve surgery is prohibitive (1, 2) . These transcatheter mitral stent valves may cause acute left ventricular outflow tract (LVOT) obstruction by displacing the anterior mitral valve leaflet towards the septum. Formal criteria have not been established, but as in surgery (3, 4) , contributors to LVOT obstruction include angulated mitral and aortic annular planes, long or redundant anterior mitral leaflets, small ventricles, bulging septums or narrow leaflet-to-septum distance (5-7). Preparatory or bailout transcoronary alcohol septal ablation can debulk the septum (8, 9) , but risks important myocardial and conduction system injury. Moreover, alcohol septal ablation is not feasible when the septal thickness is normal, and typically requires a delay of 4-6 weeks for remodeling before TMVR, in highly symptomatic patients. The anterior mitral leaflet can be resected during hybrid surgical TMVR but requires cardiopulmonary bypass [Mayra Guerrero, Personal Communication and reference (1) ]. We propose a transcatheter alternative.
We describe a simple catheter technique to prevent LVOT obstruction by transecting the anterior mitral valve leaflet, called laceration of the anterior mitral leaflet to prevent outflow obstruction (LAMPOON). The procedure uses an electrified guidewire that traverses the leaflet base, between two retrograde aortic catheters, and which then is pulled outward toward the leaflet tip [FIGURE 1 A, B]. The split anterior mitral leaflet no longer obstructs the LVOT after stent valve implantation, and is displaced around the implant by intact chordae tendinae
[FIGURE 1 C-F]. We developed and tested the technique in vivo and ex vivo in swine.
METHODS
LAMPOON technique
The technique has two steps: leaflet traversal followed by leaflet laceration [FIGURE 2].
Traversal is intended to be performed before, and laceration after, positioning of the transcatheter mitral valve. This would allow rapid valve implantation during expected hemodynamic compromise from intended mitral leaflet laceration. , and then deliberately kinked to confine the denuded section to the inner curvature. The original insulating Piggyback is positioned to mark and abut one margin of the denuded shaft, locked in place, and then the kinked denuded section is positioned at the intended laceration site. The guiding catheter tips are apposed within 2-5 mm to provide mechanical and electrical protection during laceration. The guidewire-catheter relationships are locked using torque devices, and the guidewire is clamped to an electrosurgery pencil. To lacerate, both locked guiding catheters are retracted during brief two-step electrification. Retraction force was measured using a force meter (ZP-11, Imada). Afterwards, the guiding catheters are further apposed, and one guidewire limb pulled through to allow catheter removal.
Animal procedures
Non-survival procedures on Yorkshire swine (51 ± 7 kg) were approved by the institutional
animal care and use committee and conducted according to contemporary NIH guidelines.
Bilateral percutaneous femoral artery and vein introducer sheaths were placed during isofluorane anesthesia with mechanical ventilation, animals received intravenous heparin (150 i.u./kg) to achieve an activated clotting time > 350s. Biplane X-ray fluoroscopy (Artis Zee, Siemens) and intracardiac echocardiography (Acunav 8.5Fr, Siemens) guided procedures. Euthanasia and necropsy were performed hours after the procedure.
To test the consequences of wrong crossing along the aorto-mitral curtain, an intentionally high traversal and laceration was performed. To test whether flowing blood would obscure thermal injury, the procedure was also performed in another heparinized animal, immediately after euthanasia.
At the conclusion of these non-survival experiments, animals were euthanized. In all animals, the mitral and aortic structures were examined carefully for thermal or mechanical injury. The laceration positions and lengths were recorded.
Transcatheter mitral valve implants were not performed in these naïve animals absent a suitable fixation mechanism, and instead were performed ex-vivo. Native LVOT length (from aortic root to mitral annulus) and minimum LVOT antero-posterior diameter were measured in explanted hearts following in vivo LAMPOON. Transcatheter heart valves (23mm Sapien 3, Edwards) were implanted at the benchtop at a 70:30 ventricular position across the annulus and LVOT geometry was measured with-and without LAMPOON modification.
In vitro heating
We performed infrared photography (FLIR E40, FLIR Inc, Portland, OR) to test focal mid-shaft heating during electrification of the insulation-stripped guidewire. A two-catheter and guidewire
crossing system was partially submerged in a saline bath including the electrosurgery indifferent electrode, and held in place by a steel clamp to simulate potential electrical coupling with a transcatheter mitral valve [FIGURE 3B].
Imaging and data analysis
Post-procedure contrast-enhanced CT was performed on a 320-row volume scanner (Aquilion One Vision, Toshiba). Surface renderings were generated on an image processing workstation (Vitrea v6.7, Toshiba).
Data are expressed as mean ± standard deviation. LVOT diameters were compared, before and after simulated TMVR with-and without LAMPOON, using one-way ANOVA and a Student t-test with Dunnet's correction for multiple comparisons (Prism v6, Graphpad Inc.).
Results
In vivo findings
The LAMPOON procedure was performed in seven live animals, and in one heparinized postmortem animal. A representative procedure is depicted in [FIGURE 2 ]. The procedure was successful in all animals. The mean procedure time was 55 ± 22 minutes, including imaging but excluding anesthesia and vascular access. LAMPOON caused mean blood pressure to fall 44% (54 ± 6 to 30 ± 4mm Hg, p<0.01), as expected, but remained steady until planned euthanasia for approximately 4 hours. Retraction force was high (50kg, 5.1kg) with an intact and electrified lacerating guidewire in vivo; retraction force was reduced (to 15N, 1.5kg) using a denuded cutting surface surrounded by an insulated polymer jacket.
In one animal, the traversal was intentionally performed "low" to simulate avoiding a The procedure sequence in patients would first be LAMPOON traversal and guidewire externalization, followed by pre-positioning of the TMVR device into the left atrium or unexpanded across the mitral valve, followed by LAMPOON laceration, followed by TMVR implantation. Patients without baseline severe mitral valve regurgitation might be expected to experience severe hypotension between the laceration and implantation steps, which with proper planning could be achieved quickly.
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Limitations
We use radiofrequency ablation to traverse and then lacerate the anterior mitral leaflet. Our traversal technique is the same employed to obtain transcaval access to the aorta (13, 14) , and relies on radiofrequency power concentration on the guidewire monopole tip, further insulated by the Piggyback polymer jacket. For laceration, we overcome the tendency of charge to concentrate on the outer curvature of the intentionally kinked guidewire shaft by selectively denuding the inner curvature. During laceration we minimize the length of exposed denuded guidewire by closely approximating the two guiding catheters. Both in vitro and in vivo we observed no evidence of electrical coupling to nearby conductive structures, which might heat the transcatheter mitral valve frame or hinder electrosurgical laceration (15) . This preclinical experience is limited to healthy juvenile swine, which unlike human patients have pristine non-calcified mitral leaflets and non-tortuous aligned aortas and aortomitral structures. These structures may be more difficult to align and to lacerate in patients.
Post-mortem distortion of cardiac geometry probably confounds our ex-vivo measurements of 
What is New?
LAMPOON is a catheter technique to transect the anterior mitral leaflet, in order to prevent iatrogenic left ventricular outflow tract obstruction.
What is Next?
Based on this series of preclinical experiments, LAMPOON may be ready for cautious investigation in selected patients at high risk of left ventricular outflow tract obstruction. 
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